The Aging Population - How and Where to Succeed with the Over 50 Crowd

Today’s Seniors are happy, active, and living in the communities of their choice. This independence, which is highly valued, is sustained in part through the efforts of informal caregivers and home and community-based services. While they feel good, the majority of Seniors are living with at least one chronic condition.

Spending on health care in the U.S. is on the rise and it is largely understood that the population with multiple chronic illnesses drives the majority of these costs. What is now being realized is that the majority of the chronically ill population is made up of frail Seniors. Many of these chronic diseases are preventable or, at the very least, their burden can be greatly reduced.

In, “The Aging Population - How and Where to Succeed with the Over 50 Crowd”, Insights examines the opportunities that exist for pharmaceutical companies to provide support to the health and well-being of the older population groups. Additionally, insights and analysis are provided on the key measures & diseases that make this growing patient segment an essential component of any pharmaceutical company’s future plans.

Scope

- Review of the population statistics including projections, changes in life expectancy amd dependency ratio

- Trends in healthcare spending

- Review of diseases impacting aging populations

- Competitive landscape

Table of Content:

Executive Summary

Population Statistics

Population Projections for the Aging Cohort and Subgroups

Changes In Average Life Expectancy

Dependency Ratio as an Indication of Burden

The Daily Lives of Older Americans

Attitudes and Activities of Older Americans

Impact of Healthier Lifestyle and Extended Duration of Independent Living

Nursing Home Population Levels

Daily Living Limitations

Assistance of Informal Care Givers

Prevalence of Chronic Conditions

Use of Technology (i.e. internet, cell phones) and the Enhanced Features that Accompany It (i.e. social networking sites)

Impact of Changes From Health Care Reform

Healthcare Spending

Trends in Health Spending

Costs Associated with Various Long Term Care Arrangements

Burden of Select Conditions

Strategies to Decrease Health Related Costs

Opportunities for Pharmaceutical Companies to Contribute to The Effort

Review of Diseases Impacting Aging Populations

Brief Description of Most Prevalent Conditions by Therapeutic Category

Risk Factors and Potential Outcomes of Select Conditions

Pipeline Overview

Companies Actively Involved In This Space

Competitive Landscape

Profile of Select Companies With Aging Populations as a Core Market

Novartis

Sanofi-Aventis

Merck & Takeda

Appendix